Product Code: ETC4471705 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The India Cancer Biomarkers market has experienced significant growth due to increased cancer incidence and the need for more precise diagnostic and prognostic tools. Biomarkers have played a pivotal role in early detection, personalized treatment, and monitoring of cancer patients. Various biomarkers like PSA, CA-125, and HER2 have gained prominence in diagnosing cancers and predicting treatment responses. The market is witnessing innovations in genomics and proteomics to identify novel biomarkers and advancements in diagnostic technologies, including liquid biopsy and imaging techniques. Rising awareness about cancer prevention and treatment, coupled with increasing healthcare investments, has contributed to the market`s expansion.
The cancer biomarkers market is driven by the growing burden of cancer and the need for early and precise diagnostic methods. Advances in genomics and proteomics, coupled with an increasing focus on personalized medicine, are key drivers. The availability of skilled pathologists, research in cancer biomarkers, and government support for cancer diagnosis and treatment contribute to market growth.
The India cancer biomarkers market faces challenges related to cancer diversity, cost, and data management. Cancer is a complex disease with various types and subtypes, each requiring specific biomarkers for diagnosis and treatment. Developing and validating these biomarkers can be time-consuming and expensive. Additionally, collecting and managing patient data for personalized cancer treatment is a challenge, as it involves the integration of diverse healthcare systems and databases.
The cancer biomarkers market faced challenges during the pandemic as cancer screenings and elective surgeries were postponed. Early cancer detection programs were disrupted, potentially leading to delayed diagnoses and treatments.
Prominent companies in the India Cancer Biomarkers market include F. Hoffmann-La Roche AG, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, and Bio-Rad Laboratories, Inc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cancer Biomarkers Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cancer Biomarkers Market Revenues & Volume, 2023 & 2028F |
3.3 India Cancer Biomarkers Market - Industry Life Cycle |
3.4 India Cancer Biomarkers Market - Porter's Five Forces |
3.5 India Cancer Biomarkers Market Revenues & Volume Share, By Biomarkers Type, 2023 & 2028F |
3.6 India Cancer Biomarkers Market Revenues & Volume Share, By Cancer Type, 2023 & 2028F |
3.7 India Cancer Biomarkers Market Revenues & Volume Share, By Profiling Technologies, 2023 & 2028F |
3.8 India Cancer Biomarkers Market Revenues & Volume Share, By Application, 2023 & 2028F |
4 India Cancer Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Cancer Biomarkers Market Trends |
6 India Cancer Biomarkers Market, By Types |
6.1 India Cancer Biomarkers Market, By Biomarkers Type |
6.1.1 Overview and Analysis |
6.1.2 India Cancer Biomarkers Market Revenues & Volume, By Biomarkers Type, 2020 - 2028F |
6.1.3 India Cancer Biomarkers Market Revenues & Volume, By Protein Biomarkers, 2020 - 2028F |
6.1.4 India Cancer Biomarkers Market Revenues & Volume, By Genetic Biomarkers, 2020 - 2028F |
6.1.5 India Cancer Biomarkers Market Revenues & Volume, By Other Cancer Biomarkers, 2020 - 2028F |
6.2 India Cancer Biomarkers Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 India Cancer Biomarkers Market Revenues & Volume, By Breast Cancer, 2020 - 2028F |
6.2.3 India Cancer Biomarkers Market Revenues & Volume, By Lung Cancer, 2020 - 2028F |
6.2.4 India Cancer Biomarkers Market Revenues & Volume, By Colorectal Cancer, 2020 - 2028F |
6.2.5 India Cancer Biomarkers Market Revenues & Volume, By Prostate Cancer, 2020 - 2028F |
6.2.6 India Cancer Biomarkers Market Revenues & Volume, By Melanoma, 2020 - 2028F |
6.2.7 India Cancer Biomarkers Market Revenues & Volume, By Leukemia, 2020 - 2028F |
6.2.8 India Cancer Biomarkers Market Revenues & Volume, By Bladder Cancer, 2020 - 2028F |
6.2.9 India Cancer Biomarkers Market Revenues & Volume, By Bladder Cancer, 2020 - 2028F |
6.3 India Cancer Biomarkers Market, By Profiling Technologies |
6.3.1 Overview and Analysis |
6.3.2 India Cancer Biomarkers Market Revenues & Volume, By Omics Technologies, 2020 - 2028F |
6.3.3 India Cancer Biomarkers Market Revenues & Volume, By Imaging Technologies, 2020 - 2028F |
6.3.4 India Cancer Biomarkers Market Revenues & Volume, By Immunoassay, 2020 - 2028F |
6.3.5 India Cancer Biomarkers Market Revenues & Volume, By Bioinformatics, 2020 - 2028F |
6.3.6 India Cancer Biomarkers Market Revenues & Volume, By Cytogenetics, 2020 - 2028F |
6.4 India Cancer Biomarkers Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Cancer Biomarkers Market Revenues & Volume, By Diagnostics, 2020 - 2028F |
6.4.3 India Cancer Biomarkers Market Revenues & Volume, By Research & Development, 2020 - 2028F |
6.4.4 India Cancer Biomarkers Market Revenues & Volume, By Prognostics, 2020 - 2028F |
6.4.5 India Cancer Biomarkers Market Revenues & Volume, By Risk Assessment, 2020 - 2028F |
6.4.6 India Cancer Biomarkers Market Revenues & Volume, By Other Applications, 2020 - 2028F |
7 India Cancer Biomarkers Market Import-Export Trade Statistics |
7.1 India Cancer Biomarkers Market Export to Major Countries |
7.2 India Cancer Biomarkers Market Imports from Major Countries |
8 India Cancer Biomarkers Market Key Performance Indicators |
9 India Cancer Biomarkers Market - Opportunity Assessment |
9.1 India Cancer Biomarkers Market Opportunity Assessment, By Biomarkers Type, 2023 & 2028F |
9.2 India Cancer Biomarkers Market Opportunity Assessment, By Cancer Type, 2023 & 2028F |
9.3 India Cancer Biomarkers Market Opportunity Assessment, By Profiling Technologies, 2023 & 2028F |
9.4 India Cancer Biomarkers Market Opportunity Assessment, By Application, 2023 & 2028F |
10 India Cancer Biomarkers Market - Competitive Landscape |
10.1 India Cancer Biomarkers Market Revenue Share, By Companies, 2023 |
10.2 India Cancer Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |